StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

CGONBullishAnalyst Target Updateanalyst
Medium materiality6/10

Truist Raises CG Oncology Target to $100

Nov 17, 2026, 11:08 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The target increase and implied upside are bullish, but remain an analyst forecast rather than a guaranteed outcome.

AI summary

What happened, with direct paths to the underlying reporting

Truist raised its target to $100 versus a posted price of $76.82, implying about 30% upside to the new target.

  • Truist target: $100
  • Posted price: $76.82

Key facts

  1. 01

    Target: $100

  2. 02

    Posted price: $76.82

  3. 03

    Analyst firm: Truist Financial

  4. 04

    Analyst: Greg Renza

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.